1. Home
  2. HUIZ vs AYTU Comparison

HUIZ vs AYTU Comparison

Compare HUIZ & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huize Holding Limited

HUIZ

Huize Holding Limited

N/A

Current Price

$1.98

Market Cap

31.5M

Sector

Finance

ML Signal

N/A

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

HOLD

Current Price

$2.35

Market Cap

27.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUIZ
AYTU
Founded
2006
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.5M
27.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
HUIZ
AYTU
Price
$1.98
$2.35
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$2.30
$9.33
AVG Volume (30 Days)
7.5K
104.9K
Earning Date
03-23-2026
02-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.25
N/A
Revenue
$186,519,166.00
$62,640,000.00
Revenue This Year
$22.67
N/A
Revenue Next Year
$8.55
$47.32
P/E Ratio
$7.97
N/A
Revenue Growth
19.12
2.00
52 Week Low
$1.50
$0.95
52 Week High
$4.53
$3.07

Technical Indicators

Market Signals
Indicator
HUIZ
AYTU
Relative Strength Index (RSI) 29.92 38.66
Support Level $1.86 $2.45
Resistance Level $2.25 $2.76
Average True Range (ATR) 0.12 0.16
MACD 0.02 -0.04
Stochastic Oscillator 26.67 23.88

Price Performance

Historical Comparison
HUIZ
AYTU

About HUIZ Huize Holding Limited

Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: